Steven Cohen Neogenomics Inc Transaction History

Point72 Asset Management, L.P.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$13.01 - $15.77 $15.2 Million - $18.4 Million	-1,165,943 Reduced 53.06%	1,031,608 $14.3 Million
Q1 2024 May 15, 2024	BUY	$14.06 - $16.79 $30.9 Million - $36.9 Million	2,197,551 New	2,197,551 $34.5 Million
Q3 2023 Nov 14, 2023	BUY	$12.15 - $17.85 $3.89 Million - $5.71 Million	319,986 Added 250.02%	447,972 $5.51 Million
Q2 2023 Aug 14, 2023	BUY	$14.1 - $19.83 $1.8 Million - $2.54 Million	127,986 New	127,986 $2.06 Million
Q2 2022 Aug 15, 2022	BUY	$7.06 - $13.97 $14.7 Million - $29 Million	2,075,433 New	2,075,433 $16.9 Million
Q3 2019 Nov 15, 2019	SELL	$19.12 - $26.24 $5.21 Million - $7.15 Million	-272,517 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$19.57 - $24.1 $5.33 Million - $6.57 Million	272,517 New	272,517 $5.98 Million
Q4 2018 Feb 14, 2019	SELL	$11.24 - $18.5 $327,556 - $539,127	-29,142 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$12.5 - $15.38 $364,275 - $448,203	29,142 New	29,142 $447,000

295

125M

698K

120K

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $2.06B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.